MEGADETH’s DAVE MUSTAINE Thanks Fans For Support After Cancer Diagnosis

Dave Mustaine Cancer Treatment

Dave Mustaine has thanked his family, friends and fans for their support in the week since he announced he was diagnosed with throat cancer.

MEGADETH mainman revealed his cancer diagnosis last week on social media. He said that he has already begun treatment as part of a plan that his doctors feel has a “90% success rate.”

Mustaine has now released a brief video message in which he said: “Hi. I wanted to take a moment real quick and thank my family, my friends and the best fans in the world for all of your support and love the last few days. We’re gonna beat this thing together.”

MEGADETH was forced to cancel all of their 2019 dates with the exception of Megacruise which is still going according to plan.

MEGADETH has recently entered a studio in Franklin, Tennessee to start recording the follow-up to 2016’s Dystopia album.

In February, Mustaine talked about the new album with Kerrang.

“We’re trying to keep with that real heavy thing.” Dave said. Dystopia was more of us doing what makes us feel good; there’s a lot of super-heavy, fast drumming at the end of some songs.

“My son was in here two days ago, and when we were doing Dystopia, he was listening to the songs and making comments, and the ones he commented on were the ones that got the best response. When he came over this time, we were working on a song that has the tentative title ‘The Dogs Of Chernobyl’, and the intro riff has kind of a Hungarian guitar part, kind of like something MERCYFUL FATE did on ‘Into The Coven’. The song comes in super powerful and strong, and my son goes, ‘Oh god, that’s heavy as hell!’ and I just started laughing.”

MEGADETH‘s latest album, Dystopia opened with 48,000 copies, marking MEGADETH‘s highest-charting album since 1992’s Countdown To Extinction debuted and peaked at No. 2 on the chart dated August 1 of that year. Dystopia also logs the group’s best sales week since 2007, when United Abominations landed at No. 8 with first-week sales of 54,000.